AAO 2020: Considerations when using anti-VEGF for treating AMD

Conference|AAO

Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.


Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.

Related Videos
Related Content

Roche Canada completes negotiations with the pCPA for VABYSMO® to treat wet AMD and DME

May 30th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

iHealthScreen Inc. applies for FDA 510K Submission for iPredict™, an AI-based, software as a medical device tool to diagnosis AMD

May 24th 2023

What to expect from virtual AAO 2020

November 5th 2020

AiViva Biopharma Inc. begins Phase 1 trial for AI007 for the treatment of wet AMD and DME

May 23rd 2023

Espansione Group announces second major research effort for photobiomodulation (PBM) technology.

May 12th 2023

Roche Canada completes negotiations with the pCPA for VABYSMO® to treat wet AMD and DME

May 30th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

iHealthScreen Inc. applies for FDA 510K Submission for iPredict™, an AI-based, software as a medical device tool to diagnosis AMD

May 24th 2023

What to expect from virtual AAO 2020

November 5th 2020

AiViva Biopharma Inc. begins Phase 1 trial for AI007 for the treatment of wet AMD and DME

May 23rd 2023

Espansione Group announces second major research effort for photobiomodulation (PBM) technology.

May 12th 2023

Roche Canada completes negotiations with the pCPA for VABYSMO® to treat wet AMD and DME

May 30th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

iHealthScreen Inc. applies for FDA 510K Submission for iPredict™, an AI-based, software as a medical device tool to diagnosis AMD

May 24th 2023

What to expect from virtual AAO 2020

November 5th 2020

AiViva Biopharma Inc. begins Phase 1 trial for AI007 for the treatment of wet AMD and DME

May 23rd 2023

Espansione Group announces second major research effort for photobiomodulation (PBM) technology.

May 12th 2023
© 2023 MJH Life Sciences

All rights reserved.